Endobronchial Ultrasound Biopsy Market Size, Share, and Growth Analysis, By Product (EBUS Scopes, EBUS Needles), By Procedure (EBUS-Transbronchial Needle Aspiration (EBUS-TBNA), EBUS-Guided Biopsy), By End use, By Region - Industry Forecast 2025-2032

Global Endobronchial Ultrasound Biopsy Market size was valued at USD 710.0 million in 2023 and is poised to grow from USD 744.79 million in 2024 to USD 1092.04 million by 2032, growing at a CAGR of 4.9% during the forecast period (2025-2032).

The endobronchial ultrasound biopsy (EBUS) market is witnessing steady growth, fueled by a global emphasis on early lung cancer diagnosis and a transition towards less invasive techniques. Innovations in EBUS technology, such as enhanced scopes, needles, and ultrasound processors, significantly improve procedure precision, bolstering demand from hospitals and specialty clinics. Additionally, an aging global population and rising rates of respiratory diseases, including COPD and tuberculosis, are amplifying the need for EBUS diagnostics, especially in advanced economies and emerging markets like Japan, China, and India. However, market growth faces challenges from high equipment and procedure costs, which limit adoption in cost-sensitive environments, alongside inconsistent reimbursement policies in low- to middle-income regions. Despite these hurdles, hospitals and ambulatory care centers express strong interest, particularly with demonstrable clinical pathways and funding support.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Endobronchial Ultrasound Biopsy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Endobronchial Ultrasound Biopsy Market Segments Analysis

Global Endobronchial Ultrasound Biopsy Market is segmented by Product, Procedure, End use and region. Based on Product, the market is segmented into EBUS Scopes, EBUS Needles, Ultrasound Processors & Imaging Systems and Accessories. Based on Procedure, the market is segmented into EBUS-Transbronchial Needle Aspiration (EBUS-TBNA) and EBUS-Guided Biopsy. Based on End use, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Endobronchial Ultrasound Biopsy Market

The Global Endobronchial Ultrasound Biopsy market is primarily driven by the increasing incidence of lung cancer and various pulmonary diseases worldwide. Endobronchial Ultrasound (EBUS) Biopsy procedures offer a minimally invasive method for obtaining samples from mediastinal and hilar lymph nodes, essential for staging and diagnosing lung malignancies. As health awareness grows globally, countries are emphasizing the significance of early detection, leading to a rise in lung cancer screening programs across both developed and developing healthcare economies. Furthermore, as healthcare systems transition, there is a rising demand for alternatives to traditional surgical pathology and flexible bronchoscopy, enhancing the prominence of EBUS-TBNA and resulting in increased clinical demand as hospitals adapt to higher procedural volumes in respiratory and oncology practices.

Restraints in the Global Endobronchial Ultrasound Biopsy Market

Despite advancements in clinical technology, the global endobronchial ultrasound biopsy (EBUS) market faces significant restraints due to high costs associated with acquiring, maintaining, and implementing EBUS systems. This economic barrier disproportionately affects smaller healthcare facilities and institutions in low- and middle-income countries, where the financial burden of capital equipment, disposable biopsy needles, and annual servicing is particularly challenging. As a result, the adoption of EBUS technology is often limited to large tertiary hospitals or academic centers, hindering market growth and restricting patient access to these advanced diagnostic tools. Additionally, the absence of efficient procurement options or volume-based subsidies exacerbates this issue, making it increasingly difficult for health administrators to integrate EBUS systems effectively and deliver enhanced care.

Market Trends of the Global Endobronchial Ultrasound Biopsy Market

The Global Endobronchial Ultrasound Biopsy (EBUS) market is witnessing a transformative trend driven by the integration of artificial intelligence (AI) in imaging and navigation. This advancement facilitates more precise identification of lymph nodes and lesions, significantly enhancing biopsy accuracy and reducing variance between operators. The utilization of AI algorithms not only streamlines diagnostic processes, particularly for early-stage lung cancer, but also leads to shorter procedure times and improved patient outcomes. Healthcare organizations adopting AI-enabled EBUS platforms are experiencing increased efficiency, marking a pivotal shift in technological and clinical practices within the healthcare landscape. As such, this trend is shaping the future of EBUS procedures globally.